LitCovid-sample-Enju  

PMC:7253482 / 26259-27036 JSONTXT 20 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T1371 0-7 RB denotes Overall
T1372 7-8 -COMMA- denotes ,
T1373 9-13 DT denotes this
T1374 14-19 NN denotes study
T1375 20-24 VBZ denotes adds
T1376 25-32 JJ denotes further
T1377 33-41 NN denotes evidence
T1378 42-52 VBG denotes suggesting
T1379 53-57 IN denotes that
T1380 58-67 JJ denotes extensive
T1381 68-76 JJ denotes N-linked
T1382 77-83 NN denotes glycan
T1383 84-97 NNS denotes modifications
T1384 98-100 IN denotes of
T47921 101-105 NNP denotes SARS
T1386 106-109 CC denotes and
T1387 110-114 NNP denotes MERS
T1388 115-118 NN denotes CoV
T1389 119-120 NN denotes S
T1390 121-129 NNS denotes proteins
T1391 130-132 VBP denotes do
T1392 133-136 RB denotes not
T1393 137-147 VB denotes constitute
T1394 148-150 DT denotes an
T1395 151-160 JJ denotes effective
T1396 161-167 NN denotes shield
T1397 167-168 -COMMA- denotes ,
T1398 169-171 IN denotes in
T1399 172-182 NN denotes comparison
T1400 183-185 TO denotes to
T1401 186-192 NN denotes glycan
T1402 193-200 NNS denotes shields
T1403 201-203 IN denotes of
T1404 204-211 JJ denotes certain
T1405 212-217 JJ denotes other
T1406 218-225 NNS denotes viruses
T1407 225-226 -COMMA- denotes ,
T1408 227-232 WDT denotes which
T1409 233-235 VBZ denotes is
T1410 236-245 VBN denotes reflected
T1411 246-248 IN denotes by
T1412 249-252 DT denotes the
T1413 253-260 JJ denotes overall
T1414 261-270 NN denotes structure
T1415 270-271 -COMMA- denotes ,
T1416 272-279 NN denotes density
T1417 280-283 CC denotes and
T1418 284-296 NN denotes oligomannose
T1419 297-306 NN denotes abundance
T1420 307-313 IN denotes across
T1421 314-317 DT denotes the
T1422 318-331 VBG denotes corresponding
T1423 332-340 JJ denotes trimeric
T1424 341-354 NNS denotes glycoproteins
T1425 356-358 PRP denotes We
T1426 359-363 RB denotes also
T1427 364-375 VBP denotes demonstrate
T1428 376-380 IN denotes that
T1429 381-391 JJ denotes amino-acid
T1430 392-407 NN denotes diversification
T1431 408-414 RB denotes indeed
T1432 415-421 VBZ denotes occurs
T1433 422-424 IN denotes at
T1434 425-433 NN denotes antibody
T1435 434-444 JJ denotes accessible
T1436 445-452 NNS denotes regions
T1437 453-455 IN denotes on
T1438 456-459 DT denotes the
T1439 460-466 NN denotes trimer
T1440 466-467 -COMMA- denotes ,
T1441 468-473 WDT denotes which
T1442 474-482 VBZ denotes confirms
T1443 483-487 IN denotes that
T1444 488-495 NNS denotes glycans
T1445 496-500 VBP denotes play
T1446 501-502 DT denotes a
T1447 503-507 NN denotes role
T1448 508-510 IN denotes in
T1449 511-520 VBG denotes occluding
T1450 521-529 JJ denotes specific
T1451 530-537 NNS denotes regions
T1452 538-540 IN denotes if
T1453 541-554 NN denotes vulnerability
T1454 555-557 IN denotes on
T1455 558-561 DT denotes the
T1456 562-574 NN denotes glycoprotein
T1457 576-587 RB denotes Furthermore
T1458 587-588 -COMMA- denotes ,
T1459 589-600 NNS denotes comparisons
T1460 601-608 IN denotes between
T1461 609-615 NN denotes glycan
T1462 616-623 NNS denotes shields
T1463 624-628 IN denotes from
T1464 629-630 DT denotes a
T1465 631-637 NN denotes number
T1466 638-640 IN denotes of
T1467 641-648 NNS denotes viruses
T1468 649-658 VBP denotes highlight
T1469 659-662 DT denotes the
T1470 663-673 NN denotes importance
T1471 674-676 IN denotes of
T1472 677-678 DT denotes a
T1473 679-685 NN denotes glycan
T1474 686-692 NN denotes shield
T1475 693-695 IN denotes in
T1476 696-702 JJ denotes immune
T1477 703-710 NN denotes evasion
T1478 711-714 CC denotes and
T1479 715-721 VBP denotes reveal
T1480 722-732 JJ denotes structural
T1481 733-743 NNS denotes principles
T1482 744-748 WDT denotes that
T1483 749-755 VBP denotes govern
T1484 756-769 NN denotes glycosylation
T1485 770-776 NN denotes status
R1407 T1375 T1371 arg1Of adds,Overall
R1408 T1375 T1372 arg1Of adds,","
R1409 T1374 T1373 arg1Of study,this
R1411 T1377 T1375 arg2Of evidence,adds
R1412 T1377 T1376 arg1Of evidence,further
R1413 T1377 T1378 arg1Of evidence,suggesting
R1414 T1393 T1378 arg2Of constitute,suggesting
R1415 T1393 T1379 arg1Of constitute,that
R1416 T1383 T1380 arg1Of modifications,extensive
R1417 T1383 T1381 arg1Of modifications,N-linked
R1418 T1383 T1382 arg1Of modifications,glycan
R1419 T1383 T1384 arg1Of modifications,of
R1420 T1390 T1384 arg2Of proteins,of
R1421 T1390 T47921 arg1Of proteins,SARS
R1422 T47921 T1386 arg1Of SARS,and
R1423 T1387 T1386 arg2Of MERS,and
R1424 T1390 T1387 arg1Of proteins,MERS
R1425 T1390 T1388 arg1Of proteins,CoV
R1426 T1390 T1389 arg1Of proteins,S
R1427 T1383 T1391 arg1Of modifications,do
R1428 T1393 T1391 arg2Of constitute,do
R1429 T1393 T1392 arg1Of constitute,not
R1430 T1383 T1393 arg1Of modifications,constitute
R1431 T1396 T1393 arg2Of shield,constitute
R1432 T1396 T1394 arg1Of shield,an
R1433 T1396 T1395 arg1Of shield,effective
R1434 T1393 T1397 arg1Of constitute,","
R1435 T1393 T1398 arg1Of constitute,in
R1436 T1399 T1398 arg2Of comparison,in
R1437 T1399 T1400 arg1Of comparison,to
R1438 T1402 T1400 arg2Of shields,to
R1439 T1402 T1401 arg1Of shields,glycan
R1440 T1402 T1403 arg1Of shields,of
R1441 T1406 T1403 arg2Of viruses,of
R1442 T1406 T1404 arg1Of viruses,certain
R1443 T1406 T1405 arg1Of viruses,other
R1444 T1377 T1407 arg1Of evidence,","
R1445 T1377 T1408 arg1Of evidence,which
R1446 T1377 T1409 arg1Of evidence,is
R1447 T1410 T1409 arg2Of reflected,is
R1448 T1414 T1410 arg1Of structure,reflected
R1449 T1377 T1410 arg2Of evidence,reflected
R1450 T1414 T1411 arg2Of structure,by
R1451 T1414 T1412 arg1Of structure,the
R1452 T1414 T1413 arg1Of structure,overall
R1453 T1414 T1415 arg1Of structure,","
R1454 T1417 T1415 arg2Of and,","
R1455 T1416 T1417 arg1Of density,and
R1456 T1419 T1417 arg2Of abundance,and
R1457 T1419 T1418 arg1Of abundance,oligomannose
R1458 T1417 T1420 arg1Of and,across
R1459 T1424 T1420 arg2Of glycoproteins,across
R1460 T1424 T1421 arg1Of glycoproteins,the
R1461 T1424 T1422 arg1Of glycoproteins,corresponding
R1462 T1424 T1423 arg1Of glycoproteins,trimeric
R1463 T1427 T1426 arg1Of demonstrate,also
R1464 T1425 T1427 arg1Of We,demonstrate
R1465 T1432 T1427 arg2Of occurs,demonstrate
R1466 T1432 T1428 arg1Of occurs,that
R1467 T1430 T1429 arg1Of diversification,amino-acid
R1468 T1432 T1431 arg1Of occurs,indeed
R1469 T1430 T1432 arg1Of diversification,occurs
R1470 T1432 T1433 arg1Of occurs,at
R1471 T1436 T1433 arg2Of regions,at
R1472 T1436 T1434 arg1Of regions,antibody
R1474 T1436 T1437 arg1Of regions,on
R1475 T1439 T1437 arg2Of trimer,on
R1476 T1439 T1438 arg1Of trimer,the
R1477 T1439 T1440 arg1Of trimer,","
R1478 T1439 T1441 arg1Of trimer,which
R1479 T1439 T1442 arg1Of trimer,confirms
R1480 T1445 T1442 arg2Of play,confirms
R1481 T1445 T1443 arg1Of play,that
R1482 T1444 T1445 arg1Of glycans,play
R1483 T1447 T1445 arg2Of role,play
R1484 T1447 T1446 arg1Of role,a
R1485 T1445 T1448 arg1Of play,in
R1486 T1449 T1448 arg2Of occluding,in
R1487 T1451 T1449 arg2Of regions,occluding
R1488 T1451 T1450 arg1Of regions,specific
R1489 T1451 T1452 arg1Of regions,if
R1490 T1453 T1452 arg2Of vulnerability,if
R1491 T1453 T1454 arg1Of vulnerability,on
R1492 T1456 T1454 arg2Of glycoprotein,on
R1493 T1456 T1455 arg1Of glycoprotein,the
R1494 T1478 T1457 arg1Of and,Furthermore
R1495 T1478 T1458 arg1Of and,","
R1496 T1459 T1460 arg1Of comparisons,between
R1497 T1462 T1460 arg2Of shields,between
R1498 T1462 T1461 arg1Of shields,glycan
R1499 T1462 T1463 arg1Of shields,from
R1500 T1465 T1463 arg2Of number,from
R1501 T1465 T1464 arg1Of number,a
R1502 T1465 T1466 arg1Of number,of
R1503 T1467 T1466 arg2Of viruses,of
R1504 T1459 T1468 arg1Of comparisons,highlight
R1505 T1470 T1468 arg2Of importance,highlight
R1506 T1470 T1469 arg1Of importance,the
R1507 T1470 T1471 arg1Of importance,of
R1508 T1474 T1471 arg2Of shield,of
R1509 T1474 T1472 arg1Of shield,a
R1510 T1474 T1473 arg1Of shield,glycan
R1511 T1474 T1475 arg1Of shield,in
R1512 T1477 T1475 arg2Of evasion,in
R1513 T1477 T1476 arg1Of evasion,immune
R1515 T1479 T1478 arg2Of reveal,and
R1516 T1459 T1479 arg1Of comparisons,reveal
R1517 T1481 T1479 arg2Of principles,reveal
R1518 T1481 T1480 arg1Of principles,structural
R1519 T1481 T1482 arg1Of principles,that
R1520 T1481 T1483 arg1Of principles,govern
R1521 T1485 T1483 arg2Of status,govern
R1522 T1485 T1484 arg1Of status,glycosylation
R30471 T1374 T1375 arg1Of study,adds
R74870 T1468 T1478 arg1Of highlight,and
R84867 T1436 T1435 arg1Of regions,accessible